- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x NCT: (S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE(Non-covalent)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 1 residues within 4Å:- Chain A: N.91
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.91
NAG.12: 1 residues within 4Å:- Chain B: N.91
No protein-ligand interaction detected (PLIP)NAG.21: 1 residues within 4Å:- Chain C: N.91
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.91
NAG.29: 2 residues within 4Å:- Chain D: G.90, N.91
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.91
NAG.39: 2 residues within 4Å:- Chain E: G.90, N.91
No protein-ligand interaction detected (PLIP)- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 9 residues within 4Å:- Chain A: A.109, Y.110, S.111, S.112, M.143
- Chain B: Q.55, V.70, L.119, A.137
Ligand excluded by PLIPEDO.4: 5 residues within 4Å:- Chain A: Y.186, S.188
- Chain E: C.144, D.145, C.157
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: Q.55, S.184, Y.186
- Chain E: S.111, M.143
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: P.38, W.103, Y.166
- Chain B: I.123
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: D.29, L.30, R.33, M.83, W.84, Y.89
Ligand excluded by PLIPEDO.13: 8 residues within 4Å:- Chain B: A.109, Y.110, S.111, S.112, M.143
- Chain C: Q.55, V.70, L.119
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: C.144, D.145, C.157
- Chain B: Y.186, S.188
Ligand excluded by PLIPEDO.17: 5 residues within 4Å:- Chain A: S.111, M.143
- Chain B: Q.55, S.184, Y.186
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain B: P.38, W.103, Y.166
- Chain C: R.96, I.123
Ligand excluded by PLIPEDO.22: 8 residues within 4Å:- Chain C: A.109, Y.110, S.111, S.112
- Chain D: Q.55, V.70, L.119, A.137
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain B: S.111, M.143
- Chain C: Q.55, S.184, Y.186
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain C: P.38, W.103, Y.166
- Chain D: K.27, I.123
Ligand excluded by PLIPEDO.30: 8 residues within 4Å:- Chain D: A.109, Y.110, S.111, S.112, M.143
- Chain E: Q.55, V.70, L.119
Ligand excluded by PLIPEDO.31: 4 residues within 4Å:- Chain C: C.144, D.145
- Chain D: Y.186, S.188
Ligand excluded by PLIPEDO.34: 4 residues within 4Å:- Chain C: M.143
- Chain D: Q.55, S.184, Y.186
Ligand excluded by PLIPEDO.35: 4 residues within 4Å:- Chain D: P.38, W.103, Y.166
- Chain E: I.123
Ligand excluded by PLIPEDO.36: 6 residues within 4Å:- Chain D: R.33, M.83, W.84, D.85, E.88, Y.89
Ligand excluded by PLIPEDO.40: 9 residues within 4Å:- Chain A: Q.55, V.70, L.119, A.137
- Chain E: A.109, Y.110, S.111, S.112, M.143
Ligand excluded by PLIPEDO.41: 4 residues within 4Å:- Chain D: C.144, D.145
- Chain E: Y.186, S.188
Ligand excluded by PLIPEDO.44: 5 residues within 4Å:- Chain D: Y.110, M.143
- Chain E: Q.55, S.184, Y.186
Ligand excluded by PLIP- 10 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.5: 5 residues within 4Å:- Chain A: S.167, E.170, E.210
- Chain B: D.94, R.96
6 PLIP interactions:3 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:S.167, A:E.170, A:E.210
- Water bridges: B:R.96, B:R.96
- Salt bridges: B:R.96
PO4.6: 5 residues within 4Å:- Chain A: K.59, D.68, R.139, S.141
- Chain E: R.114
7 PLIP interactions:5 interactions with chain A, 2 interactions with chain E- Hydrogen bonds: A:D.68, A:D.68, A:S.141
- Salt bridges: A:K.59, A:R.139, E:R.114
- Water bridges: E:R.114
PO4.15: 6 residues within 4Å:- Chain B: S.167, F.169, E.170, E.210
- Chain C: D.94, R.96
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain C- Hydrogen bonds: B:S.167, B:E.170, B:E.170, B:E.210, C:D.94
- Salt bridges: C:R.96
PO4.16: 6 residues within 4Å:- Chain A: R.114
- Chain B: K.59, D.68, R.114, R.139, S.141
7 PLIP interactions:5 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:S.141
- Water bridges: B:R.114, B:R.114, A:R.114
- Salt bridges: B:K.59, B:R.139, A:R.114
PO4.23: 5 residues within 4Å:- Chain C: S.167, E.170, E.210
- Chain D: D.94, R.96
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:D.94, C:S.167, C:S.167
- Salt bridges: D:R.96
PO4.24: 5 residues within 4Å:- Chain B: R.114
- Chain C: K.59, D.68, R.139, S.141
11 PLIP interactions:8 interactions with chain C, 3 interactions with chain B- Hydrogen bonds: C:S.141, C:S.141
- Water bridges: C:E.66, C:E.66, C:D.68, C:D.68, B:R.114, B:R.114
- Salt bridges: C:K.59, C:R.139, B:R.114
PO4.32: 6 residues within 4Å:- Chain D: S.167, F.169, E.170, E.210
- Chain E: D.94, R.96
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain E- Hydrogen bonds: D:S.167, D:E.210, E:D.94
- Salt bridges: E:R.96
PO4.33: 5 residues within 4Å:- Chain C: R.114
- Chain D: K.59, D.68, R.139, S.141
9 PLIP interactions:7 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:D.68, D:S.141, D:S.141
- Water bridges: D:R.114, D:R.114, C:R.114
- Salt bridges: D:K.59, D:R.139, C:R.114
PO4.42: 6 residues within 4Å:- Chain A: D.94, R.96
- Chain E: S.167, F.169, E.170, E.210
5 PLIP interactions:4 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:S.167, E:E.170, E:E.210, E:E.210
- Salt bridges: A:R.96
PO4.43: 6 residues within 4Å:- Chain D: R.114
- Chain E: K.59, D.68, R.114, R.139, S.141
8 PLIP interactions:2 interactions with chain D, 6 interactions with chain E- Water bridges: D:R.114, E:K.59
- Salt bridges: D:R.114, E:K.59, E:R.139
- Hydrogen bonds: E:R.114, E:S.141, E:S.141
- 5 x IPA: ISOPROPYL ALCOHOL(Non-functional Binders)
IPA.10: 4 residues within 4Å:- Chain A: Q.20, N.22, L.23
- Chain E: D.43
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain E- Hydrophobic interactions: A:N.22, E:D.43
- Hydrogen bonds: A:N.22, A:L.23
IPA.19: 5 residues within 4Å:- Chain A: D.43
- Chain B: Q.20, A.21, N.22, L.23
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:N.22, A:D.43
- Hydrogen bonds: B:N.22, B:L.23
IPA.27: 7 residues within 4Å:- Chain B: T.41, D.43
- Chain C: Q.20, A.21, N.22, L.23, I.92
5 PLIP interactions:4 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:Q.20, C:Q.20, C:N.22, C:L.23
- Hydrophobic interactions: B:D.43
IPA.37: 7 residues within 4Å:- Chain C: T.41, D.43
- Chain D: Q.20, A.21, N.22, L.23, I.92
5 PLIP interactions:1 interactions with chain C, 4 interactions with chain D- Hydrophobic interactions: C:D.43
- Hydrogen bonds: D:Q.20, D:Q.20, D:N.22, D:L.23
IPA.45: 7 residues within 4Å:- Chain D: T.41, D.43
- Chain E: Q.20, A.21, N.22, L.23, I.92
6 PLIP interactions:5 interactions with chain E, 1 interactions with chain D- Hydrophobic interactions: E:I.92, D:D.43
- Hydrogen bonds: E:Q.20, E:Q.20, E:N.22, E:L.23
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dawson, A. et al., Engineering a surrogate human heteromeric alpha / beta glycine receptor orthosteric site exploiting the structural homology and stability of acetylcholine-binding protein. Iucrj (2019)
- Release Date
- 2018-06-27
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
GC
HD
IE
J
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x NCT: (S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE(Non-covalent)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 10 x PO4: PHOSPHATE ION(Non-functional Binders)
- 5 x IPA: ISOPROPYL ALCOHOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dawson, A. et al., Engineering a surrogate human heteromeric alpha / beta glycine receptor orthosteric site exploiting the structural homology and stability of acetylcholine-binding protein. Iucrj (2019)
- Release Date
- 2018-06-27
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
GC
HD
IE
J